Andiely Lu, M.D., is a Senior Investment Manager with Lilly Asia Ventures (LAV). Prior to joining LAV, Andiely worked at L.E.K. Consulting as a core member of L.E.K. Asia-Pacific Life Sciences Practice, where he led and supported multiple projects across biotech and medtech sectors. Prior to that, Andiely was a PRC certified physician and served at Tongji Hospital Huazhong University of Science and Technology (HUST). Andiely holds an M.D. in GI Surgery and an M.B.B.S. in Clinical Medicine from Tongji Medical College of HUST.